XBD173

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XBD173, covering 2010-05-20 to 2010-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder [Phase 2]